Intero Biosystems wants drugmakers to test on mini human intestines, not animals
THE SO WHAT
Lab-grown human intestines as a testing platform shift drug discovery from animal models to organoid infrastructure. If regulators keep nudging away from animal testing, pharma R&D roadmaps and tooling budgets will tilt toward organoid vendors and the data stacks around them.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging TechChip Rout Deepens as Rate Fears Collide With AI Funding Woes
Higher-for-longer rates plus tighter AI funding is a double hit to capex-heavy chip roadmaps—marginal projects and speculative AI silicon are the first to slip. If you’re counting on cheaper or more abundant GPUs in your 2027+ plans, build a downside scenario where that relief comes later and costs more.
Deep & Emerging TechIndia's NIIF Eyes $800M Data Center Investment
NIIF steering up to $800M into data centers is another proof point that India wants to be an AI and cloud compute zone, not just a user market. If you’re planning regional latency or data residency strategies, assume India will have credible local capacity and start negotiating long-term power and land early.
Deep & Emerging TechA concrete thermal battery could be key to cooling data centers at scale — 150Kw prototype that can withstand up to 500 degrees centigrade is running
Thermal storage moving into concrete form factors is a direct response to AI data center heat and power constraints. If 150 kWh units pencil out, expect site selection and cooling design to shift toward co-optimizing land, materials, and waste heat reuse, not just cheap electrons.
Deep & Emerging TechRocket Lab’s stock slides as the company pushes back Neutron’s first launch
Neutron’s delay reinforces how hard it is to bring a Falcon 9-class launcher online—and how dependent downstream space businesses are on a thin set of reliable rockets. If your roadmap assumes medium-lift capacity, build in schedule slack and dual-source launch options now.